Concepedia

Therapeutic Interchangeability

Therapeutic Interchangeability is a regulatory and clinical concept denoting the substitution of one therapeutic product for another within the same therapeutic class, where both products are expected to achieve comparable clinical outcomes and safety profiles in a given patient population under standardized conditions of use.

21

Publications

546

Citations

110

Authors

54

Institutions

Publications per year

2017–2026

4

Parents

Publications

21

Modeling and Comparison of Dissolution Profiles of Diltiazem Modified-Release Formulations

D. Samaha, R. Shehayeb, Soula Kyriacos · Dissolution Technologies · 2009 · 93 citations · Full text

, , +17

Biosimilars: Policy, clinical, and regulatory considerations

Scott Gottlieb · American Journal of Health-System Pharmacy · 2008 · 57 citations

, , +17

Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease

Gionata Fiorino, M. Begoña Ruiz-Argüello, A Maguregui et al. · Inflammatory Bowel Diseases · 2018 · 53 citations · Full text

, , +15

Branded versus generic clozapine: bioavailability comparison and interchangeability issues.

Y. W. Francis Lam, Larry Ereshefsky, G B Toney et al. · PubMed · 2001 · 43 citations

, , +17

ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution

David R. Holmes, Jeffrey A. Becker, Christopher B. Granger et al. · Journal of the American College of Cardiology · 2011 · 30 citations

, , +12

1–5 of 21

Authors

110

  1. DJ
    Daan J.A. Crommelin

    Utrecht University, Netherlands

    2 publications · 43 citations

    2

    h-index

  2. JM
    José Morais

    Université Libre de Bruxelles, Belgium

    2 publications · 43 citations

    2

    h-index

  3. MC
    Mei‐Ling Chen

    University of British Columbia, Canada

    2 publications · 43 citations

    2

    h-index

  4. HC
    Hans C. Ebbers

    Utrecht University, Netherlands

    2 publications · 35 citations

    2

    h-index

  5. LS
    Leon Shargel

    Northeastern University, United States

    2 publications · 43 citations

    2

    h-index

1–5 of 110

Institutions

54

  1. Cleveland Clinic

    Cleveland, United States

    2 h-index

    2 publications

    34 citations

  2. SocraTec R&D (Germany)

    Erfurt, Germany

    2 h-index

    2 publications

    43 citations

  3. Spring Valley Hospital

    Spring Valley, United States

    2 h-index

    2 publications

    43 citations

  4. Utrecht University

    Utrecht, The Netherlands

    2 h-index

    4 publications

    70 citations

  5. United States Food and Drug Administration

    Silver Spring, United States

    2 h-index

    6 publications

    129 citations

  6. International Pharmaceutical Federation

    The Hague, Netherlands

    2 h-index

    2 publications

    43 citations

  7. Pharmo Institute

    Utrecht, Netherlands

    2 h-index

    2 publications

    43 citations

  8. Thomas Jefferson University

    Philadelphia, United States

    2 h-index

    2 publications

    43 citations

1–8 of 54

Venues

  1. American Journal of Health-System Pharmacy

    AJHP · 4 publications · 105 citations

    4

    h-index

  2. PubMed

    Repository · 3 publications · 74 citations

    3

    h-index

  3. Generics and Biosimilars Initiative Journal

    2 publications · 35 citations

    2

    h-index

  4. Dissolution Technologies

    1 publications · 93 citations

    1

    h-index

  5. Journal of the American College of Cardiology

    JACC · 1 publications · 30 citations

    1

    h-index

1–5